Depression Unveiled: Current Understanding and Pathways to Recovery
DOI:
https://doi.org/10.64261/vjtak127Keywords:
Depression, Neurobiology, Risk Factors, Diagnosis, Neuroimaging, PsychotherapyAbstract
Depression is a complex mental illness and one of the largest global public health issues which impacts over 280 million people worldwide. It is predetermined with the constant low mood, absence of pleasure (anhedonia), impaired thinking and dysfunction, and it is the result of the complicated interplay of genetic and biological, psychological and environmental factors. Depression theories date back to humoral melancholia ideas and were transformed in relation to earlier psychoanalytic interpretations to the modern biopsychosocial and neurobiological model. The studies of the present day accentuate structural and functional dysfunctions of principal brain areas, impairments of neurotransmitter networks, adaptive stress reactions, and neuroinflammation as the main factors of the origins of depression. Poverty, discrimination, low levels of education, and poor access to healthcare are all social determinants that make people even more vulnerable and slow down their recovery process. Pharmacotherapy, psychotherapeutic modalities, and lifestyle modification are evidence-based interventions, whereas neuromodulation therapies, including electroconvulsive therapy and transcranial magnetic stimulation, are also effective interventions in people with treatment-resistant depression. New therapies, such as ketamine-based therapies, anti-inflammatory, and precision care based on pharmacogenetic are emerging to provide new avenues to quick and specific symptom treatment. Integrated management is needed in the form of long-term recovery, which facilitates psychosocial support, resilience, reintegration into the community, and functional restoration. The future of the world in the diagnostics and treatment of depression has a high potential due to advancements in neuroscience, personalized medicine, and digital therapeutics, which can bring more specific, effective, and available treatment.
References
1. Adroa Afiya B. Interconnection between Depressive Disorders and Persistent Diseases. Res Invention J Res Med Sci. 2024;3(1):45-51.
2. Minas H. Depression in the developing world. Depression: Law and Ethics. 2017:186-98.
3. Weems CF, Carrion V, McCurdy B, Scozzafava MD. Increased risk of suicide due to economic and social impacts of social distancing measures to address the Covid-19 pandemic: A forecast. Res Prepr. 2020;9(926):10.13140.
4. Nemeroff CB. The state of our understanding of the pathophysiology and optimal treatment of depression: glass half full or half empty? American Journal of Psychiatry. 2020;177(8):671-85.
5. Brouwers EP. Social stigma is an underestimated contributing factor to unemployment in people with mental illness or mental health issues: position paper and future directions. BMC psychology. 2020;8(1):36.
6. Noetel M, Sanders T, Gallardo-Gómez D, Taylor P, del Pozo Cruz B, Van Den Hoek D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. bmj. 2024;384.
7. Chen XD, Li F, Zuo H, Zhu F. Trends in Prevalent Cases and Disability-Adjusted Life-Years of Depressive Disorders Worldwide: Findings From the Global Burden of Disease Study From 1990 to 2021. Depress Anxiety. 2025;2025:5553491.
8. Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, De Silva M, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. The lancet. 2007;370(9591):991-1005.
9. Kouba BR, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues ALS. Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets. Cells. 2024;13(5):423.
10. Aggarwal S, Wright J, Morgan A, Patton G, Reavley N. Religiosity and spirituality in the prevention and management of depression and anxiety in young people: a systematic review and meta-analysis. BMC Psychiatry. 2023;23(1):729.
11. Pop M. Normal and abnormal and the body-soul relationship in some ancient medical texts. Balkan Journal of Philosophy. 2012;4(2):185-96.
12. Zivanovic O, Nedic A. Kraepelin's concept of manic-depressive insanity: One hundred years later. Journal of affective disorders. 2012;137(1-3):15-24.
13. Tripathi A, Das A, Kar SK. Biopsychosocial model in contemporary psychiatry: Current validity and future prospects. Indian journal of psychological medicine. 2019;41(6):582-5.
14. Buch AM, Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021;46(1):156-75.
15. Stein DJ, Shoptaw SJ, Vigo DV, Lund C, Cuijpers P, Bantjes J, et al. Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration. World Psychiatry. 2022;21(3):393-414.
16. EDITION F. Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC. 1980:205-24.
17. Lopizzo N, Bocchio Chiavetto L, Cattane N, Plazzotta G, Tarazi FI, Pariante CM, et al. Gene–environment interaction in major depression: focus on experience-dependent biological systems. Frontiers in psychiatry. 2015;6:68.
18. Nordquist N, Oreland L. Serotonin, genetic variability, behaviour, and psychiatric disorders-a review. Upsala journal of medical sciences. 2010;115(1):2-10.
19. Jiang Y, Zou D, Li Y, Gu S, Dong J, Ma X, et al. Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals. 2022;15(10):1203.
20. Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of psychosomatic research. 2002;53(4):865-71.
21. Beck AT, Bredemeier K. A unified model of depression: Integrating clinical, cognitive, biological, and evolutionary perspectives. Clinical Psychological Science. 2016;4(4):596-619.
22. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. American journal of psychiatry. 2008;165(8):969-77.
23. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatric clinics. 2012;35(1):51-71.
24. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychological bulletin. 2014;140(3):774.
25. Shi L, Stevens GD. Vulnerability and unmet health care needs: the influence of multiple risk factors. Journal of general internal medicine. 2005;20(2):148-54.
26. Minihan S, Orben A, Songco A, Fox E, Ladouceur CD, Mewton L, et al. Social determinants of mental health during a year of the COVID-19 pandemic. Dev Psychopathol. 2023;35(4):1701-13.
27. Ma J, Wu J, Marois G. Socioeconomic inequalities in depression and the role of job conditions in China. Front Public Health. 2024;12:1464187.
28. Ridley M, Rao G, Schilbach F, Patel V. Poverty, depression, and anxiety: Causal evidence and mechanisms. Science. 2020;370(6522):eaay0214.
29. Bonnefoy X. Inadequate housing and health: an overview. International journal of environment and pollution. 2007;30(3-4):411-29.
30. Brandt L, Liu S, Heim C, Heinz A. The effects of social isolation stress and discrimination on mental health. Translational psychiatry. 2022;12(1):398.
31. Thornicroft G. Stigma and discrimination limit access to mental health care. Epidemiology and Psychiatric Sciences. 2008;17(1):14-9.
32. Vargas SM, Huey Jr SJ, Miranda J. A critical review of current evidence on multiple types of discrimination and mental health. American Journal of Orthopsychiatry. 2020;90(3):374.
33. Kirkbride JB, Anglin DM, Colman I, Dykxhoorn J, Jones PB, Patalay P, et al. The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry. 2024;23(1):58-90.
34. Dean J, Keshavan M. The neurobiology of depression: An integrated view. Asian journal of psychiatry. 2017;27:101-11.
35. Nihalani N, Simionescu M, Dunlop BW. Depression: phenomenology, epidemiology, and pathophysiology. Depression: CRC Press; 2009. p. 13-33.
36. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and anxiety. 2000;12(S1):2-19.
37. Liu Y, Zhao J, Guo W. Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders. Frontiers in psychology. 2018;9:2201.
38. Höflich A, Michenthaler P, Kasper S, Lanzenberger R. Circuit mechanisms of reward, anhedonia, and depression. International Journal of Neuropsychopharmacology. 2019;22(2):105-18.
39. Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102(1):75-90.
40. Hiser J, Koenigs M. The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology. Biological psychiatry. 2018;83(8):638-47.
41. Gao W, Yan X, Yuan J. Neural correlations between cognitive deficits and emotion regulation strategies: understanding emotion dysregulation in depression from the perspective of cognitive control and cognitive biases. Psychoradiology. 2022;2(3):86-99.
42. Tartt AN, Mariani MB, Hen R, Mann JJ, Boldrini M. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol Psychiatry. 2022;27(6):2689-99.
43. Adolphs R, Spezio M. Role of the amygdala in processing visual social stimuli. Progress in brain research. 2006;156:363-78.
44. Sheena MK, Jimmy J, Burkhouse KL, Klumpp H. Anterior cingulate cortex activity during attentional control corresponds with rumination in depression and social anxiety. Psychiatry Research: Neuroimaging. 2021;317:111385.
45. Taylor AM, Becker S, Schweinhardt P, Cahill C. Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction. Pain. 2016;157(6):1194-8.
46. Sharan P, Vellapandian C. Hypothalamic-pituitary-adrenal (HPA) axis: Unveiling the potential mechanisms involved in stress-induced Alzheimer’s disease and depression. Cureus. 2024;16(8).
47. Hasenmajer V, Bonaventura I, Minnetti M, Sada V, Sbardella E, Isidori AM. Non-canonical effects of ACTH: insights into adrenal insufficiency. Frontiers in Endocrinology. 2021;12:701263.
48. Bernardes BM, de Oliveira Borba MC, Moreira S, Sartori CS, da Silva Júnior IF, de Souza MTL, et al. Relationship between Mood Disorders and Thyroid Changes. Brazilian Journal of Implantology and Health Sciences. 2024;6(2):2241-56.
49. Babaeeghazvini P, Rueda-Delgado LM, Gooijers J, Swinnen SP, Daffertshofer A. Brain structural and functional connectivity: A review of combined works of diffusion magnetic resonance imaging and electro-encephalography. Frontiers in Human Neuroscience. 2021;15:721206.
50. Fournier JC, Bertocci M, Ladouceur CD, Bonar L, Monk K, Abdul-Waalee H, et al. Neural function during emotion regulation and future depressive symptoms in youth at risk for affective disorders. Neuropsychopharmacology. 2021;46(7):1340-7.
51. Legrum S. Adult adhd comorbidity with posttraumatic stress disorder and acute reaction to stress: Vilniaus universitetas.; 2025.
52. Cardoner N, Andero R, Cano M, Marin-Blasco I, Porta-Casteràs D, Serra-Blasco M, et al. Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders. Curr Neuropharmacol. 2024;22(5):935-62.
53. Zhou Y, Wei L, Gao S, Wang J, Hu Z. Characterization of diffusion magnetic resonance imaging revealing relationships between white matter disconnection and behavioral disturbances in mild cognitive impairment: a systematic review. Frontiers in neuroscience. 2023;17:1209378.
54. Singh SB, Tiwari A, Katta MR, Kafle R, Ayubcha C, Patel KH, et al. The utility of PET imaging in depression. Front Psychiatry. 2024;15:1322118.
55. Goes FS. Diagnosis and management of bipolar disorders. Bmj. 2023;381:e073591.
56. Liu RT, Walsh RFL, Sheehan AE, Cheek SM, Sanzari CM. Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022;79(7):718-26.
57. Kaur R, Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803-12.
58. Niu M, Zhang Y, Zhang X, Yangyang C, Zhuang X, Li J, et al. Dissection of the clinical phenome of major depressive disorder into subdomains and subgroups in relation to activated immune-inflammatory profiles. medRxiv. 2025:2025.10. 21.25338439.
59. Platona RI, Căiţă GA, Voiţă-Mekeres F, Peia AO, Enătescu RV. The impact of psychiatric comorbidities associated with depression: a literature review. Med Pharm Rep. 2024;97(2):143-8.
60. Marx W, Penninx BW, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. Nature Reviews Disease Primers. 2023;9(1):44.
61. Rolin D, Whelan J, Montano CB. Is it depression or is it bipolar depression? J Am Assoc Nurse Pract. 2020;32(10):703-13.
62. Senaratne H, Oviatt S, Ellis K, Melvin G. A critical review of multimodal-multisensor analytics for anxiety assessment. ACM Transactions on Computing for Healthcare. 2022;3(4):1-42.
63. Berk M, Köhler‐Forsberg O, Turner M, Penninx BW, Wrobel A, Firth J, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World psychiatry. 2023;22(3):366-87.
64. Appleton HD. An Exploration of the Presence and Behavioural Manifestation of Anxiety in Children and Young Adults with Autism Spectrum Disorder and Intellectual Disability. 2022.
65. Karrouri R, Hammani Z, Benjelloun R, Otheman Y. Major depressive disorder: Validated treatments and future challenges. World journal of clinical cases. 2021;9(31):9350.
66. Gao K, Oruc EB, Koparal B. Pharmacological Monotherapy for Depressive Disorders: Current and Future-A Narrative Review. Medicina (Kaunas). 2025;61(4).
67. Miguel C, Karyotaki E, Ciharova M, Cristea IA, Penninx B, Cuijpers P. Psychotherapy for comorbid depression and somatic disorders: a systematic review and meta-analysis. Psychol Med. 2023;53(6):2503-13.
68. Sejbuk M, Mirończuk-Chodakowska I, Witkowska AM. Sleep quality: a narrative review on nutrition, stimulants, and physical activity as important factors. Nutrients. 2022;14(9):1912.
69. Shafique H, Demers JC, Biesiada J, Golani LK, Cerne R, Smith JL, et al. (R)-(-)-ketamine: the promise of a novel treatment for psychiatric and neurological disorders. International journal of molecular sciences. 2024;25(12):6804.
70. Monaco F, Vignapiano A, Piacente M, Farina F, Pagano C, Marenna A, et al. Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder. Frontiers in artificial intelligence. 2024;7:1366055.
71. Chang JP-C, Zamparelli A, Nettis M, Pariante C. Antidepressant drugs: mechanisms of action and side effects. Encyclopedia of Behavioral Neuroscience. 2022;1:V1-613.
72. Zhou Y, Zhao D, Zhu X, Liu L, Meng M, Shao X, et al. Psychological interventions for the prevention of depression relapse: systematic review and network meta-analysis. Transl Psychiatry. 2023;13(1):300.
73. Ruiz A, Haseeb A, Baumgartner W, Lueng E, Scaini G, De Quevedo JL. New insights into the mechanisms of electroconvulsive therapy in treatment-resistant depression. Frontiers in psychiatry. 2025;16:1614076.
74. Adadzi J, Kerna NA. Optimizing Major Depression Management by Integrating Physical Activity and Targeted Lifestyle Changes. Authorea Preprints. 2024.
75. Halaris A, Cook J. The glutamatergic system in treatment-resistant depression and comparative effectiveness of ketamine and esketamine: role of inflammation? Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders: Springer; 2023. p. 487-512.
76. Ibrahim MMA. The role of psychotherapy and pharmacotherapy in managing major depressive disorder. Int J Psychol Sci. 2025;7(1):18-27.
77. Van den Eynde V, Abdelmoemin WR, Abraham MM, Amsterdam JD, Anderson IM, Andrade C, et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS spectrums. 2023;28(4):427-40.
78. Dagher M. Investigating Changes in Monoamine Transmission Induced by Stress: University of California, Los Angeles; 2022.
79. Qi X. Neuropharmacology of Neurotransmitter Systems: Current Drugs and Their Effects on Neural and Neuroendocrine Pathways. Asia Pacific Journal of Clinical Medical Research. 2025;1(1).
80. Terpos E, Mikhael J, Hajek R, Chari A, Zweegman S, Lee HC, et al. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal. 2021;11(2):40.
81. Lin J, Liu W, Guan J, Cui J, Shi R, Wang L, et al. Latest updates on the serotonergic system in depression and anxiety. Frontiers in Synaptic Neuroscience. 2023;15:1124112.
82. Mazreno B, Taghian A. F.(2023). Fatigue in Aging: The Influence of Serotonin and Potential Therapeutic Strategies. Journal of Humanistic approach to sport and exercise studies (HASES).3(3):512-22.
83. Edinoff AN, Swinford CR, Odisho AS, Burroughs CR, Stark CW, Raslan WA, et al. Clinically relevant drug interactions with monoamine oxidase inhibitors. Health psychology research. 2022;10(4):39576.
84. Bar-Kalifa E, Bringmann LF, Zilcha-Mano S. The role of affect dynamics as mechanisms of change in mental health interventions: Integrating applied and basic science. Journal of Consulting and Clinical Psychology. 2024;92(8):445.
85. Salkovskis PM, Sighvatsson MB, Sigurdsson JF. How effective psychological treatments work: mechanisms of change in cognitive behavioural therapy and beyond. Behavioural and cognitive psychotherapy. 2023;51(6):595-615.
86. Zhang X. Effects of Posttraumatic Cognitions, Working Alliance, and Relational Intimacy Skills in PTSD Treatment: Marquette University; 2024.
87. Oberoi T. Common Mechanisms of Change in Mindfulness-Based Cognitive Therapy (MBCT) and Traditional Cognitive Behavioral Therapy (CBT): Implications for Therapeutic Effectiveness. The National High School Journal of Science; 2024.
88. Wang X, Feng Z. A narrative review of empirical literature of behavioral activation treatment for depression. Frontiers in Psychiatry. 2022;13:845138.
89. Burback L, Brult-Phillips S, Nijdam MJ, McFarlane A, Vermetten E. Treatment of posttraumatic stress disorder: a state-of-the-art review. Current neuropharmacology. 2024;22(4):557-635.
90. Xie Y, Wu Z, Sun L, Zhou L, Wang G, Xiao L, et al. The effects and mechanisms of exercise on the treatment of depression. Frontiers in psychiatry. 2021;12:705559.
91. Naragatti S. The Role of Yoga in Balancing Hormones: A Comprehensive Research Review. International Journal For Multidisciplinary Research. 2025;7(1):1-12.
92. Lu EY, Cheng AS, Tsang HW, Chen J, Leung S, Yip A, et al. Psychoeducation, motivational interviewing, cognitive remediation training, and/or social skills training in combination for psychosocial functioning of patients with schizophrenia spectrum disorders: A systematic review and meta-analysis of randomized controlled trials. Frontiers in psychiatry. 2022;13:899840.
93. Antos Z, Żukow X, Bursztynowicz L, Jakubów P. Beyond NMDA Receptors: A Narrative Review of Ketamine’s Rapid and Multifaceted Mechanisms in Depression Treatment. International Journal of Molecular Sciences. 2024;25(24):13658.
94. Bhatt S, Devadoss T, Jha NK, Baidya M, Gupta G, Chellappan DK, et al. Targeting inflammation: a potential approach for the treatment of depression. Metabolic Brain Disease. 2023;38(1):45-59.
95. Jain N, Nagaich U, Pandey M, Chellappan DK, Dua K. Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements. EPMA Journal. 2022;13(4):561-80.
96. Scangos KW, State MW, Miller AH, Baker JT, Williams LM. New and emerging approaches to treat psychiatric disorders. Nature medicine. 2023;29(2):317-33.
97. Rymaszewska J, Wieczorek T, Fila-Witecka K, Smarzewska K, Weiser A, Piotrowski P, et al. Various neuromodulation methods including Deep Brain Stimulation of the medial forebrain bundle combined with psychopharmacotherapy of treatment-resistant depression—Case report. Frontiers in Psychiatry. 2023;13:1068054.
98. Chen X, Zhang T, Shan X, Yang Q, Zhang P, Zhu H, et al. High-frequency repetitive transcranial magnetic stimulation alleviates the cognitive side effects of electroconvulsive therapy in major depression. Frontiers in Psychiatry. 2022;Volume 13 - 2022.
99. Korai SA, Ranieri F, Di Lazzaro V, Papa M, Cirillo G. Neurobiological after-effects of low intensity transcranial electric stimulation of the human nervous system: from basic mechanisms to metaplasticity. Frontiers in Neurology. 2021;12:587771.
100. Naik A, Chu T, Gupta R, Saadah B, Gangidi S, Lee C, et al. Deep brain stimulation for treatment-resistant major depressive disorder: a network meta-analysis of stimulation targets. J Neurosurg. 2025:1-10.
101. Deif R, Salama M. Depression from a precision mental health perspective: utilizing personalized conceptualizations to guide personalized treatments. Frontiers in psychiatry. 2021;12:650318.
102. Campos AI, Mulcahy A, Thorp JG, Wray NR, Byrne EM, Lind PA, et al. Understanding genetic risk factors for common side effects of antidepressant medications. Communications medicine. 2021;1(1):45.
103. Jani J, Lin CLS, Mudin DKD, Muniandy RK. Bridging the genetic gulf: a deep dive into neurotransmission, pharmacogenomics, and genetic variations for optimal pain management. Neuroscience Research Notes. 2024;7(2):316.1-.15.
104. Kobeissy F, Goli M, Yadikar H, Shakkour Z, Kurup M, Haidar MA, et al. Advances in neuroproteomics for neurotrauma: unraveling insights for personalized medicine and future prospects. Frontiers in neurology. 2023;14:1288740.
105. Asghar S, Virk MKS, Taskeen B, Fatima M, Wandala A. The role of pharmacogenomics in Advancing Personalised Medicine: Implications for Drug Efficacy Safety and clinical practice Integration. Indus Journal of Bioscience Research. 2025;3(5):637-45.
106. Jadhav OP, Choure V. TELEMEDICINE: TRANSFORMING HEALTHCARE DELIVERY IN THE DIGITAL AGE. Int J Acad Med Pharm. 2024;6(3):565-71.
107. Cogiel K, Sawina A, Guzowska A, Lau K, Kasperczyk J. Managing chronic disease in the digital era: The role of telemedicine apps and platforms. Przegl Epidemiol. 2025;79(1):83-94.
108. Shahzadi N. Improving Access to Healthcare for Rural Populations: Strategies and Solutions. Multidisciplinary Journal of Healthcare (MJH). 2024;1(1):42-52.
109. Grande D, Marti XL, Feuerstein-Simon R, Merchant RM, Asch DA, Lewson A, et al. Health policy and privacy challenges associated with digital technology. JAMA network open. 2020;3(7):e208285-e.
110. Watanabe TK, Esquenazi A, Flanagan S. The transformation of the rehabilitation paradigm across the continuum of care. PM&R. 2018;10(9):S264-S71.
111. Killaspy H. Contemporary Mental Health Rehabilitation: Keeping it Simple in a Complex World. World Social Psychiatry. 2023;5(1):51-4.
112. Morris ME, Perry A, Bilney B, Curran A, Dodd K, Wittwer JE, et al. Outcomes of physical therapy, speech pathology, and occupational therapy for people with motor neuron disease: a systematic review. Neurorehabilitation and neural repair. 2006;20(3):424-34.
113. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nature reviews Disease primers. 2020;6(1):11.
114. Safran DG, Graham JD, Osberg JS. Social supports as a determinant of community-based care utilization among rehabilitation patients. Health Services Research. 1994;28(6):729.
115. Besemann LM, Hebert J, Thompson JM, Cooper RA, Gupta G, Brémault-Phillips S, et al. Reflections on recovery, rehabilitation and reintegration of injured service members and veterans from a bio-psychosocial-spiritual perspective. Canadian Journal of Surgery. 2018;61(6 Suppl 1):S219.
116. Tol WA, Barbui C, Galappatti A, Silove D, Betancourt TS, Souza R, et al. Mental health and psychosocial support in humanitarian settings: linking practice and research. The Lancet. 2011;378(9802):1581-91.
117. Smit D, Miguel C, Vrijsen JN, Groeneweg B, Spijker J, Cuijpers P. The effectiveness of peer support for individuals with mental illness: systematic review and meta-analysis. Psychol Med. 2023;53(11):5332-41.
118. DeLancey JOL, Masteling M, Pipitone F, LaCross J, Mastrovito S, Ashton-Miller JA. Pelvic floor injury during vaginal birth is life-altering and preventable: what can we do about it? Am J Obstet Gynecol. 2024;230(3):279-94.e2.
119. Downing J, Sjeklocha L. Trauma in Pregnancy. Emerg Med Clin North Am. 2023;41(2):223-45.
120. Sylaska KM, Edwards KM. Disclosure of intimate partner violence to informal social support network members: A review of the literature. Trauma, violence, & abuse. 2014;15(1):3-21.
121. Kendall E, Catalano T, Kuipers P, Posner N, Buys N, Charker J. Recovery following stroke: the role of self-management education. Social science & medicine. 2007;64(3):735-46.
122. Sano Y, Mammen S, Houghten M. Well-being and stability among low-income families: A 10-year review of research. Journal of Family and Economic Issues. 2021;42(Suppl 1):107-17.
123. Levasseur M, Routhier S, Clapperton I, Doré C, Gallagher F. Social participation needs of older adults living in a rural regional county municipality: Toward reducing situations of isolation and vulnerability. BMC geriatrics. 2020;20(1):456.
124. Bhaskar S, Bradley S, Chattu VK, Adisesh A, Nurtazina A, Kyrykbayeva S, et al. Telemedicine as the new outpatient clinic gone digital: position paper from the pandemic health system REsilience PROGRAM (REPROGRAM) international consortium (Part 2). Frontiers in public health. 2020;8:410.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Pan-African Journal of Health and Psychological Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Pan-African Journal of Health and Psychological Sciences (PAJHPS) are open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license:
-
Authors retain copyright and grant the journal the right of first publication.
-
The work may be shared, copied, redistributed, and adapted for any purpose, even commercially.
-
Appropriate credit must be given to the original author(s) and the journal, along with a link to the license.
-
Users must indicate if changes were made.
-
There are no restrictions on reuse, provided the original work is properly cited.
Citation:
Authors and users must cite the original work in the following manner:
Author(s). (Year). Title of the article. Pan-African Journal of Health and Psychological Sciences, Volume(Issue), page range. https://doi.org/xx.xxxx/pajhps.vXnY.xxx
Copyright Statement:
Authors grant PAJHPS a non-exclusive license to publish the work and identify itself as the original publisher. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version (e.g., post it to a repository or publish it in a book), with acknowledgment of its initial publication in this journal.
